Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Completed

Conditions studied: Enterobacteriaceae Infections

In brief

This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.

Key facts

Study ID

NCT00573521

Run by

University of Pittsburgh

People needed

450

Starts

2007-11-01

Expected to finish

2017-06-01

Last updated by the study team

2018-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical information is collected by chart review of "case" and "control" patients.
• A "case A" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam resistant.
• A "case B" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam susceptible.
• Additionally, 1 control patient in the hospital at the same time as the case patients will be randomly selected for each case and are not in either case group.

You may not qualify if…

• Patients < 18 years of age

Where it is running

• UPMC — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.